Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
- 24 August 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Pleura and Peritoneum
- Vol. 2 (3) , 129-136
Abstract
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has changed treatment for selected patients with peritoneal metastases (PM) arising from appendiceal, colorectal, epithelial ovarian, primary peritoneal and gastric cancers. However, the results of CRS with HIPEC remain unclear in PM from other tumor histologies. Methods: We report a series of 10 patients who underwent CRS and HIPEC between 2006 and 2015, for PM arising from uncommon tumor origins. Results: Ten patients with PM from uncommon tumor origins underwent CRS and HIPEC. Median age was 46.5 years. Two patients had ovarian Sertoli-Leydig cell tumors (SLCT) and two had small bowel adenocarcinomas. The other histologies included: ovarian transitional cell carcinoma, ovarian granulosa cell tumor, endometroid adenocarcinoma, endocervical adenocarcinoma, synovial sarcoma, and ovarian leiomyosarcoma. Median peritoneal cancer index was 9 (2–18) and complete cytoreduction was achieved for all patients. Median follow-up was 14 months (2–100), and median time to recurrence from CRS and HIPEC was 16.0 months by Kaplan–Meier estimate. Four patients remain alive and disease-free, five are alive with disease, and one had died with disease. Median survival was not reached. Conclusions: Eight of ten patients with peritoneal metastases in the above rare indications survived 10 months or more after CRS and HIPEC. These encouraging results are a rationale for prospective clinical trials in these tumor histologies.Keywords
This publication has 39 references indexed in Scilit:
- A clinicopathological analysis of 40 cases of ovarian Sertoli–Leydig cell tumorsGynecologic Oncology, 2012
- Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective studyBMC Cancer, 2011
- Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective studyJournal of Gynecologic Oncology, 2011
- A Comparative Study of Complete Cytoreductive Surgery Plus Intraperitoneal Chemotherapy to Treat Peritoneal Dissemination From Colon, Rectum, Small Bowel, and Nonpseudomyxoma AppendixAnnals of Surgery, 2010
- Characteristics of recurrence in adult-type granulosa cell tumorInternational Journal of Gynecological Cancer, 2008
- Aggressive Surgical Management of Peritoneal Carcinomatosis With Low Mortality in a High-Volume Tertiary Cancer CenterAnnals of Surgical Oncology, 2007
- Combination Chemotherapy in Advanced Small Bowel AdenocarcinomaOncology, 2005
- Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinomaJournal of Surgical Oncology, 2005
- Mucinous adenocarcinoma of the small bowel with peritoneal seedingEuropean Journal of Surgical Oncology, 2002
- Surgical management of peritoneal carcinosis: Diagnosis, prevention and treatmentLangenbeck's Archives of Surgery, 1988